Ligand profile
ZINC470265
Virtual-screening candidate from ZINC.
Bound to: KP13_00117 — N-acetylmuramic acid 6-phosphate etherase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC470265- UniProt (similar protein)
Q14397- Tanimoto
- 0.638
- Target protein
- KP13_00117
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 40.6
- −1 ≤ LogP ≤ 5 2.91
- MW ≤ 500 Da 342.9
- LogP ≤ 5 2.91
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 40.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=S(=O)(c1cccs1)N1CCN(c2ccc(Cl)cc2)CC1O=S(=O)(c1cccs1)N1CCN(c2ccc(Cl)cc2)CC1
InChI=1S/C14H15ClN2O2S2/c15-12-3-5-13(6-4-12)16-7-9-17(10-8-16)21(18,19)14-2-1-11-20-14/h1-6,11H,7-10H2InChI=1S/C14H15ClN2O2S2/c15-12-3-5-13(6-4-12)16-7-9-17(10-8-16)21(18,19)14-2-1-11-20-14/h1-6,11H,7-10H2
AZVWANPKXSKYGG-UHFFFAOYSA-NAZVWANPKXSKYGG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 2EU
- Homolog
- Q14397
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC470265 →
- ZINC ZINC20 ZINC470265 →
- UniProt UniProt Q14397 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC470265”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00117.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 60
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).